Trial intelligence / Profile preview

Uterine flushing with hCG to improve pregnancy rates in IUI for idiopathic infertility

IRCT20220702055335N1Phase 3Completed

Sponsor
Vice Chancellor for Research
Start
Aug 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3 trial of human chorionic gonadotropin in female infertility, sponsored by Vice Chancellor for Research. Started Aug 2022; status: completed.

02

Drugs

human chorionic gonadotropin
03

Conditions

female infertility

Beyond the preview

Go deeper on IRCT20220702055335N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20220702055335N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call